{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:56:57Z","timestamp":1761991017807,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.jgar.2019.03.007","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T13:42:08Z","timestamp":1553089328000},"page":"116-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effects of laboratory capabilities on combating antimicrobial resistance, 2013\u20132016: A static model panel data analysis"],"prefix":"10.1016","volume":"19","author":[{"given":"Youwen","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2016","series-title":"Tackling drug-resistant infections globally: final report and recommendations","author":"O\u2019Neill","key":"10.1016\/j.jgar.2019.03.007_bib0005"},{"year":"2013","series-title":"Antibiotic resistance threats in the United States","author":"Centres for Disease Control and Prevention","key":"10.1016\/j.jgar.2019.03.007_bib0010"},{"key":"10.1016\/j.jgar.2019.03.007_bib0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1136\/bmj.f1493","article-title":"The true cost of antimicrobial resistance","volume":"346","author":"Smith","year":"2013","journal-title":"BMJ"},{"year":"2011","series-title":"Action plan against the rising threats from Antimicrobial Resistance","author":"European Commission","key":"10.1016\/j.jgar.2019.03.007_bib0020"},{"year":"2015","series-title":"Global action plan on antimicrobial resistance","author":"WHO","key":"10.1016\/j.jgar.2019.03.007_bib0025"},{"year":"2017","series-title":"A European one health action plan against antimicrobial resistance (AMR)","author":"European Commission","key":"10.1016\/j.jgar.2019.03.007_bib0030"},{"year":"2016","series-title":"EU Laboratory Capability Monitoring System (EULabCap) \u2013\u2014 report on 2013 survey of EU\/EEA country capabilities and capacities","author":"ECDC","key":"10.1016\/j.jgar.2019.03.007_bib0035"},{"year":"2016","series-title":"EU Laboratory Capability Monitoring System (EULabCap) \u2014 report on 2014 survey of EU\/EEA country capabilities and capacities","author":"ECDC","key":"10.1016\/j.jgar.2019.03.007_bib0040"},{"year":"2017","series-title":"EU Laboratory Capability Monitoring System (EULabCap) \u2014 report on 2015 survey of EU\/EEA country capabilities and capacities","author":"ECDC","key":"10.1016\/j.jgar.2019.03.007_bib0045"},{"year":"2018","series-title":"EU Laboratory Capability Monitoring System (EULabCap) \u2014 report on 2016 survey of EU\/EEA country capabilities and capacities","author":"ECDC","key":"10.1016\/j.jgar.2019.03.007_bib0050"},{"key":"10.1016\/j.jgar.2019.03.007_bib0055","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1128\/CMR.00025-05","article-title":"Application of molecular techniques to the study of hospital infection","volume":"19","author":"Singh","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jgar.2019.03.007_bib0060","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00001432-200208000-00005","article-title":"Molecular typing: a key tool for the surveillance and control of nosocomial infection","volume":"15","author":"Struelens","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jgar.2019.03.007_bib0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/nyas.13310","article-title":"Challenges and opportunities for whole-genome sequencing- based surveillance of antibiotic resistance","volume":"1388","author":"Schurch","year":"2017","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.jgar.2019.03.007_bib0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1473-3099(12)70268-2","article-title":"Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study","volume":"13","author":"Harris","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2019.03.007_bib0075","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3201\/eid2302.152042","article-title":"Delivering on antimicrobial resistance agenda not possible without improving fungal diagnostic capabilities","volume":"23","author":"Denning","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2019.03.007_bib0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QCO.0000000000000182","article-title":"The role of surveillance systems in confronting the global crisis of antibiotic-resistant bacteria","volume":"28","author":"Perez","year":"2015","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jgar.2019.03.007_bib0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2807\/1560-7917.ES.2017.22.46.17-00062","article-title":"National laboratory-based surveillance system for antimicrobial resistance: a successful tool to support the control of antimicrobial resistance in the Netherlands","volume":"22","author":"Altorf-van der Kuil","year":"2017","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jgar.2019.03.007_bib0090","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1080\/14787210.2016.1220303","article-title":"Statistical detection of geographic clusters of resistant Escherichia coli in a regional network with WHONET and SaTScan","volume":"14","author":"Park","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jgar.2019.03.007_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002521","article-title":"Laboratory-based prospective surveillance for community outbreaks of Shigella spp. in Argentina","volume":"7","author":"Vinas","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jgar.2019.03.007_bib0100","series-title":"Annual report of the european antimicrobial resistance surveillance network (EARS-Net)","article-title":"Surveillance of antimicrobial resistance in Europe 2016","author":"ECDC","year":"2017"},{"year":"2017","series-title":"WHO publishes list of bacteria for which new antibiotics are urgently needed","author":"WHO","key":"10.1016\/j.jgar.2019.03.007_bib0105"},{"key":"10.1016\/j.jgar.2019.03.007_bib0110","article-title":"Analysing indicators of performance, satisfaction, or safety using empirical logit transformation","volume":"352","author":"Stevens","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jgar.2019.03.007_bib0115","first-page":"206","article-title":"Econometric analysis of cross section and panel data 2e","volume":"1","author":"Wooldridge","year":"2010","journal-title":"Mit Press Books"},{"key":"10.1016\/j.jgar.2019.03.007_bib0120","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/cid\/ciu319","article-title":"The antimicrobial resistance monitoring and research (ARMoR) program: the US department of defense response to escalating antimicrobial resistance","volume":"59","author":"Lesho","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.03.007_bib0125","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/cid\/cit795","article-title":"An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae","volume":"58","author":"Schwaber","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2019.03.007_bib0130","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.patbio.2014.01.004","article-title":"Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases","volume":"62","author":"Pang","year":"2014","journal-title":"Pathol Biol"},{"key":"10.1016\/j.jgar.2019.03.007_bib0135","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.7196\/SAMJ.2015.v105i12.9926","article-title":"Molecular characterisation and epidemiological investigation of an outbreak of bla(OXA-181) carbapenemase-producing isolates of Klebsiella pneumoniae in South Africa","volume":"105","author":"Jacobson","year":"2015","journal-title":"SAMJ"},{"key":"10.1016\/j.jgar.2019.03.007_bib0140","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/651097","article-title":"Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital","volume":"31","author":"Munoz-Price","year":"2010","journal-title":"Infect Cont Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2019.03.007_bib0145","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/21505594.2016.1185577","article-title":"Clinical and laboratory considerations for the rapid detection of carbapenem-resistant Enterobacteriaceae","volume":"8","author":"Banerjee","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.jgar.2019.03.007_bib0150","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1473-3099(09)70054-4","article-title":"The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria","volume":"9","author":"Nordmann","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2019.03.007_bib0155","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3201\/eid1710.110655","article-title":"Global spread of carbapenemase-producing enterobacteriaceae","volume":"17","author":"Nordmann","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jgar.2019.03.007_bib0160","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/1469-0691.12719","article-title":"The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide","volume":"20","author":"Nordmann","year":"2014","journal-title":"Clin Microbiol Infect"},{"year":"2013","series-title":"Carbapenemase producing bacteria in Europe: interim results from the European survey on carbapenemase-producing enterobacteriaceae (EuSCAPE) project","author":"ECDC","key":"10.1016\/j.jgar.2019.03.007_bib0165"},{"key":"10.1016\/j.jgar.2019.03.007_bib0170","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2807\/1560-7917.ES2013.18.28.20525","article-title":"Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013","volume":"18","author":"Glasner","year":"2013","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jgar.2019.03.007_bib0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2807\/1560-7917.ES.2015.20.45.30062","article-title":"Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015","volume":"20","author":"Albiger","year":"2015","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.jgar.2019.03.007_bib0180","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S1473-3099(16)30257-2","article-title":"Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli","author":"Grundmann","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2019.03.007_bib0185","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhin.2018.08.005","article-title":"Survey of screening methods, rates and policies for the detection of carbapenemase producing Enterobacteriaceae in English hospitals","volume":"101","author":"Berry","year":"2018","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jgar.2019.03.007_bib0190","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1757177417705192","article-title":"Audit of the management of patients at high risk of carbapenemase-producing enterobacteriaceae (CPE): Are we ready?","volume":"18","author":"Ratnayake","year":"2017","journal-title":"J Infect Prev"},{"key":"10.1016\/j.jgar.2019.03.007_bib0195","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jac\/dkr524","article-title":"Effects of clinical breakpoint changes in CLSI guidelines 2010\/2011 and EUCAST guidelines 2011 on antibiotic susceptibility test reporting of Gram-negative bacilli","volume":"67","author":"Hombach","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2019.03.007_bib0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079130","article-title":"Change of antibiotic susceptibility testing guidelines from CLSI to EUCAST: influence on cumulative hospital antibiograms","volume":"8","author":"Wolfensberger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jgar.2019.03.007_bib0205","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.00855","article-title":"Prevention and control of antimicrobial resistant healthcare-associated infections: the microbiology laboratory rocks!","volume":"7","author":"Sim\u00f5es","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2019.03.007_bib0210","first-page":"S57","article-title":"The role of the microbiology laboratory in healthcare-associated infection prevention","volume":"60","author":"Kaleni\u0107","year":"2009","journal-title":"Int J Infect Control"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716519300761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:53:09Z","timestamp":1761990789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716519300761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":42,"alternative-id":["S2213716519300761"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2019.03.007","relation":{},"ISSN":["2213-7165"],"issn-type":[{"type":"print","value":"2213-7165"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of laboratory capabilities on combating antimicrobial resistance, 2013\u20132016: A static model panel data analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2019.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Society for Antimicrobial Chemotherapy. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}